Andreas Schäfer Selected Research

Dual Anti-Platelet Therapy

1/2022	P2Y12 inhibition in acute coronary syndromes treated with percutaneous intervention - Understanding the debate on Prasugrel or Ticagrelor.
6/2021	Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI.
1/2020	Anti-thrombotic strategies in elderly patients receiving platelet inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreas Schäfer Research Topics

Disease

21	Myocardial Infarction 04/2024 - 10/2002
19	Heart Failure 10/2022 - 10/2002
12	Cardiogenic Shock 01/2024 - 01/2017
9	ST Elevation Myocardial Infarction 04/2024 - 10/2012
9	Out-of-Hospital Cardiac Arrest 01/2024 - 01/2018
8	Stroke (Strokes) 04/2024 - 09/2016
8	Hemorrhage 04/2024 - 09/2016
7	Atrial Fibrillation 04/2024 - 08/2013
7	Thrombosis (Thrombus) 06/2021 - 05/2007
6	Coronary Artery Disease (Coronary Atherosclerosis) 04/2024 - 01/2007
6	Shock 01/2024 - 01/2018
6	Infarction (Infarctions) 01/2024 - 09/2014
5	Acute Coronary Syndrome 04/2024 - 01/2020
5	Atherosclerosis 06/2015 - 01/2004
4	Heart Arrest (Cardiac Arrest) 04/2023 - 08/2002
4	Neoplasms (Cancer) 11/2022 - 10/2017
4	Diabetes Mellitus 06/2022 - 09/2004
3	Chronic Renal Insufficiency 06/2023 - 01/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2008
3	Parkinson Disease (Parkinson's Disease) 09/2014 - 01/2012
2	Non-ST Elevated Myocardial Infarction 04/2024 - 01/2020
2	Unstable Angina 04/2024 - 01/2020
2	Aortic Valve Stenosis (Aortic Stenosis) 03/2024 - 01/2020
2	Ventricular Fibrillation 01/2024 - 04/2023
2	Tourette Syndrome (Tourette's Syndrome) 05/2023 - 01/2023
2	Movement Disorders (Movement Disorder) 05/2023 - 01/2023
2	Mitral Valve Insufficiency (Mitral Regurgitation) 04/2023 - 06/2022
2	Hypothermia 12/2022 - 01/2021
2	Hypoxia (Hypoxemia) 01/2022 - 07/2014
2	Myocarditis (Carditis) 01/2022 - 01/2020
2	Sepsis (Septicemia) 01/2021 - 01/2020
2	Coronary Stenosis (Coronary Artery Stenosis) 01/2021 - 01/2018
2	Cardiomyopathies (Cardiomyopathy) 03/2020 - 08/2016
2	Pulmonary Embolism 01/2019 - 08/2013
2	Pulmonary Edema 01/2019 - 07/2014
2	Venous Thromboembolism 07/2017 - 01/2015
2	Vascular System Injuries 01/2017 - 01/2004
2	Inflammation (Inflammations) 12/2015 - 11/2006
2	Myocardial Ischemia (Ischemic Heart Diseases) 07/2014 - 06/2008
2	Atherosclerotic Plaque (Atheroma) 01/2012 - 01/2008
2	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 08/2011 - 04/2010
1	Obstructive Lung Diseases (Obstructive Lung Disease) 04/2024
1	Abdominal Aortic Aneurysm 03/2024
1	Emergence Delirium 03/2024
1	Acute Kidney Injury (Acute Renal Failure) 06/2023

Drug/Important Bio-Agent (IBA)

9	Clopidogrel (Plavix)FDA Link 01/2022 - 02/2007
7	AnticoagulantsIBA 04/2024 - 01/2015
7	Chemokine CX3CL1IBA 06/2015 - 01/2004
7	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2014 - 01/2004
5	Prasugrel Hydrochloride FDA Link 04/2024 - 10/2012
5	ChemokinesIBA 06/2015 - 01/2004
4	Lactic Acid (Lactate)FDA LinkGeneric 06/2022 - 01/2020
3	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 04/2024 - 01/2020
3	TicagrelorIBA 04/2024 - 01/2022
3	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2022
3	IronIBA 05/2023 - 01/2012
3	Vitamin K FDA Link 01/2022 - 07/2017
3	N(4)-oleylcytosine arabinosideIBA 06/2021 - 09/2016
3	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2017 - 06/2003
3	Mineralocorticoid Receptor AntagonistsIBA 01/2017 - 06/2003
3	salicylhydroxamic acid (SHAM)IBA 03/2004 - 10/2002
2	Neurotransmitter Agents (Neurotransmitter)IBA 05/2023 - 01/2023
2	Oxygen (Dioxygen)IBA 12/2022 - 03/2022
2	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 09/2014
2	RivaroxabanIBA 01/2022 - 08/2013
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2017
2	Phosphopyruvate Hydratase (Enolase)IBA 01/2022 - 01/2021
2	edoxabanIBA 07/2017 - 09/2016
2	von Willebrand FactorIBA 01/2017 - 01/2017
2	Chemokine ReceptorsIBA 12/2015 - 06/2015
2	5- chloro- 2- (5- chlorothiophene- 2- sulfonylamino)- N- (4- (morpholine- 4- sulfonyl)phenyl)benzamideIBA 07/2014 - 11/2010
2	Superoxides (Superoxide)IBA 07/2014 - 10/2002
2	Guanylate Cyclase (Guanylyl Cyclase)IBA 11/2010 - 12/2006
2	Adenosine Diphosphate (ADP)IBA 10/2008 - 06/2008
2	Streptozocin (Streptozotocin)FDA Link 09/2007 - 05/2007
2	Rosuvastatin Calcium (Crestor)FDA Link 05/2007 - 05/2005
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2003 - 06/2003
2	trandolapril (Mavik)FDA LinkGeneric 06/2003 - 06/2003
2	Eplerenone (Inspra)FDA LinkGeneric 06/2003 - 06/2003
1	BilirubinIBA 04/2024
1	ButyrylcholinesteraseIBA 03/2024

Therapy/Procedure

24	Therapeutics 04/2024 - 10/2002
12	Percutaneous Coronary Intervention 04/2024 - 01/2017
10	Extracorporeal Membrane Oxygenation 01/2024 - 01/2017
5	Cardiopulmonary Resuscitation (CPR) 01/2024 - 01/2016
5	Induced Hypothermia 03/2023 - 01/2016
4	Transcatheter Aortic Valve Replacement 03/2024 - 01/2020
4	Secondary Prevention 03/2022 - 07/2017
4	Ligation 01/2015 - 05/2005
3	Critical Care (Surgical Intensive Care) 03/2024 - 08/2002
3	Drug Therapy (Chemotherapy) 01/2022 - 10/2017
3	Heart-Assist Devices 01/2022 - 01/2019
3	Dual Anti-Platelet Therapy 01/2022 - 01/2020
3	Stents 06/2021 - 06/2008
2	Catheters 12/2022 - 01/2022
2	Brachytherapy 11/2022 - 05/2021
2	Resuscitation 01/2020 - 01/2018
1	Lung Transplantation 04/2024
1	Transplantation 04/2024
1	Surgical Instruments (Clip) 01/2024